Off-label therapies for newborns. Miracles or mistakes?
Askin
Debbie Fraser
DF
Faculty of Nursing, University of Manitoba.
D004348:Drug Labeling; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy* / Q000451:nursing; D007363:Intensive Care Units, Neonatal / Q000458:organization & administration; D008509:Medication Systems / Q000458:organization & administration* / Q000592:standards; D017283:Neonatal Nursing / Q000458:organization & administration*; D024802:Nurse's Role; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000627:therapeutic use
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate